570
Participants
Start Date
July 9, 2019
Primary Completion Date
January 31, 2025
Study Completion Date
June 30, 2029
Albert Einstein College of Medicine, The Bronx
Geisinger Medical Center, Danville
Fox Chase Cancer Center, Philadelphia
Perelman Center for Advanced Medicine, Philadelphia
Chesapeake Urology Research Associates, Hanover
Johns Hopkins University, School of Medicine, Baltimore
University of North Carolina, Chapel Hill
Levine Cancer Institute, Charlotte
Carolina Urologic Research Center, LLC, Myrtle Beach
Emory University, Atlanta
University of Miami, Miami
H. Lee Moffitt Cancer Center & Research Institute, Tampa
University of Alabama at Birmingham, Birmingham
Urology Associates, P.C., Nashville
Vanderbilt University Medical Center, Nashville
The Ohio State University, Columbus
Comprehensive Urology -- A Division of Michigan Healthcare Professionals, Royal Oak
Michigan Medicine Rogel Cancer Center, Ann Arbor
Spectrum Health, Grand Rapids
University of Iowa, Iowa City
University of Chicago, Chicago
University of Kansas Medical Center, Kansas City
LSU Healthcare Network - Multi Specialty Clinic, Metairie
Stephenson Cancer Center, Oklahoma City
UT Southwestern Medical Center, Dallas
MD Anderson Cancer Center, Houston
The University of Texas Health Science Center at San Antonio, San Antonio
University of Colorado Anschutz Medical Campus, Aurora
University of Utah, Salt Lake City
Mayo Clinic Cancer Center, Phoenix
USC/Norris Comprehensive CA Center, Los Angeles
UCLA, Los Angeles
Hoag Memorial Hospital Presbyterian, Newport Beach
Asante Rogue Regional Medical Center, Medford
University of Washington, Seattle
Brigham and Women's Hospital, Boston
Patient-Centered Outcomes Research Institute
OTHER
University of Washington
OTHER